Publications by authors named "Matt Liu"

Claim this Profile
A
Accelerated Discovery of : A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell Malignancies.
Zhe Nie, Michael Trzoss, Andrew T Placzek, Lynnie Trzoss, Goran Krilov, Zhijian Liu, Matt Liu

J Med Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Therapeutics and Vaccines: A Race to Save Lives.
Ilona Bebenek, Roy Bannister, John Dubinion, Marie Fortin, Matt Liu

Toxicol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients.
Matt Liu, Tai-Chung Tseng, Dae Won Jun, Ming-Lun Yeh, Huy Trinh

Hepatol Int· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human -Knockin Mice.
Elena Burova, Aynur Hermann, Jie Dai, Erica Ullman, Gabor Halasz, Matt Liu

Mol Cancer Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human Knock-In Mice.
Elena Burova, Aynur Hermann, Janelle Waite, Terra Potocky, Venus Lai, Matt Liu

Mol Cancer Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines.
Frank D Sistare, Daniel Morton, Carl Alden, Joel Christensen, Douglas Keller, Matt Liu

Toxicol Pathol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Matt Yu Liu, Lorenz Poellinger, Cheryl L Walker

Cancer Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).
Matt Y Liu, Shengli Cai, Alexsandra Espejo, Mark T Bedford, Cheryl Lyn Walker

Cancer Res· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis